SpringWorks Therapeutics (SWTX) News Today $37.59 +0.13 (+0.35%) Closing price 04:00 PM EasternExtended Trading$37.88 +0.28 (+0.76%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Here's Why We're Not At All Concerned With SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn SituationApril 13 at 2:27 PM | finance.yahoo.comFirst Week of SWTX May 30th Options TradingApril 13 at 9:27 AM | nasdaq.comFmr LLC Raises Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Fmr LLC increased its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 0.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,157,960 shares of the company's stock after buyinApril 12 at 5:43 AM | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 7.1% - Here's WhySpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 7.1% - Here's What HappenedApril 11, 2025 | marketbeat.comNorges Bank Invests $6.74 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Norges Bank bought a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 186,503 shares of the company's stock, valued at approximately $6,738,00April 11, 2025 | marketbeat.comFinepoint Capital LP Increases Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Finepoint Capital LP grew its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 15.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 748,752 shares of the company's stock after purchasinApril 8, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Sells 50,547 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Massachusetts Financial Services Co. MA trimmed its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 7.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 592,645 sharApril 8, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Bought by Schroder Investment Management GroupSchroder Investment Management Group lifted its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 93.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 168,209 shares of tApril 6, 2025 | marketbeat.comVanguard Group Inc. Has $258.65 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Vanguard Group Inc. raised its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 6.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,158,871 shares of the company's stock after buying an additiApril 6, 2025 | marketbeat.comKLP Kapitalforvaltning AS Buys Shares of 12,600 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)KLP Kapitalforvaltning AS purchased a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,600 shares ofApril 6, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Up 5.5% - Time to Buy?SpringWorks Therapeutics (NASDAQ:SWTX) Shares Up 5.5% - Time to Buy?April 4, 2025 | marketbeat.comNoteworthy Monday Option Activity: SWTX, IBM, ZSApril 2, 2025 | nasdaq.comPictet Asset Management Holding SA Has $86.40 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Pictet Asset Management Holding SA increased its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 24.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,391,412 shares of the company's stock after acquiMarch 31, 2025 | marketbeat.comNEOS Investment Management LLC Grows Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)NEOS Investment Management LLC boosted its position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 51.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 30,811 shares of the company's stock after purchasing an additional 1March 31, 2025 | marketbeat.comBIT Capital GmbH Buys 8,429 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)BIT Capital GmbH lifted its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 18.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 53,539 shares of the company's stock after acquiring an additional 8,429 sharesMarch 28, 2025 | marketbeat.comSegall Bryant & Hamill LLC Has $6.99 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Segall Bryant & Hamill LLC lifted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 43.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 193,459 shares of the company'sMarch 28, 2025 | marketbeat.comCibc World Markets Corp Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Cibc World Markets Corp acquired a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 6,433 shares of the company's stock,March 27, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Stock Holdings Increased by Swiss National BankSwiss National Bank lifted its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 7.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 116,800 shares of the company's stock after purchasing an additionMarch 26, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 2.5% - Here's What HappenedSpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 2.5% - Time to Sell?March 25, 2025 | marketbeat.comTraders Buy Large Volume of SpringWorks Therapeutics Call Options (NASDAQ:SWTX)SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) was the recipient of unusually large options trading activity on Friday. Stock investors purchased 12,381 call options on the stock. This represents an increase of 105% compared to the typical volume of 6,048 call options.March 22, 2025 | marketbeat.comRaymond James Financial Inc. Takes $10.53 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Raymond James Financial Inc. purchased a new position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 291,356 shares of theMarch 21, 2025 | marketbeat.comThis Is What Whales Are Betting On SpringWorks TherapeuticsMarch 20, 2025 | nasdaq.comPlatinum Investment Management Ltd. Invests $1.69 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Platinum Investment Management Ltd. bought a new stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 46,895 shares of the companyMarch 20, 2025 | marketbeat.com4SWTX : This Is What Whales Are Betting On SpringWorks TherapeuticsMarch 18, 2025 | benzinga.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.8% - What's Next?SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 4.8% - Here's WhyMarch 18, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Short Interest Down 22.0% in FebruarySpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 7,110,000 shares, a decrease of 22.0% from the February 13th total of 9,110,000 shares. Approximately 10.3% of the company's stock are short sold. Based on an average daily trading volume, of 2,210,000 shares, the days-to-cover ratio is presently 3.2 days.March 18, 2025 | marketbeat.comBank of New York Mellon Corp Trims Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Bank of New York Mellon Corp reduced its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 13.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 195,942 shares ofMarch 16, 2025 | marketbeat.comSpringWorks Shares Rise More Than 30% in 3 Months: Here's WhyMarch 12, 2025 | msn.comPeninsula biotech raises $35 million, looks to move quickly into late-stage mesothelioma trialMarch 12, 2025 | bizjournals.comVictory Capital Management Inc. Reduces Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Victory Capital Management Inc. cut its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 2.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 614,923March 12, 2025 | marketbeat.comSpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A BuzzMarch 11, 2025 | seekingalpha.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Candriam S.C.A.Candriam S.C.A. cut its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 80.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 164,015 shares of the company's stock after selling 681,155 shares during the peMarch 8, 2025 | marketbeat.comCheck Out What Whales Are Doing With SWTXMarch 7, 2025 | benzinga.comSpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading Volume - What's Next?SpringWorks Therapeutics (NASDAQ:SWTX) Sees Strong Trading Volume - Time to Buy?March 7, 2025 | marketbeat.comStock Traders Purchase High Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX)SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) was the recipient of some unusual options trading activity on Thursday. Stock investors bought 13,068 call options on the stock. This is an increase of approximately 223% compared to the average daily volume of 4,050 call options.March 7, 2025 | marketbeat.comBadreddin Edris Sells 20,000 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) StockSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) COO Badreddin Edris sold 20,000 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $54.23, for a total value of $1,084,600.00. Following the sale, the chief operating officer now owns 169,712 shares in the company, valued at $9,203,481.76. This represents a 10.54 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.March 6, 2025 | marketbeat.comInsider Selling: SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) CEO Sells 49,000 Shares of StockSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) CEO Saqib Islam sold 49,000 shares of SpringWorks Therapeutics stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $54.24, for a total transaction of $2,657,760.00. Following the transaction, the chief executive officer now owns 954,869 shares in the company, valued at approximately $51,792,094.56. The trade was a 4.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.March 6, 2025 | marketbeat.comInsider Selling: SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) COO Sells 20,000 Shares of StockMarch 6, 2025 | insidertrades.comInvestors push SpringWorks Therapeutics (NASDAQ:SWTX) 4.9% lower this week, company's increasing losses might be to blameMarch 5, 2025 | finance.yahoo.comWhy SpringWorks Therapeutics (SWTX) Is Skyrocketing So Far in 2025March 4, 2025 | msn.comSpringWorks Therapeutics (NASDAQ:SWTX) Trading Down 6% - Here's What HappenedSpringWorks Therapeutics (NASDAQ:SWTX) Trading Down 6% - Here's What HappenedMarch 4, 2025 | marketbeat.comShort Interest in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Decreases By 36.7%SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) was the target of a large drop in short interest in February. As of February 15th, there was short interest totalling 9,110,000 shares, a drop of 36.7% from the January 31st total of 14,400,000 shares. Based on an average daily trading volume, of 1,980,000 shares, the short-interest ratio is presently 4.6 days.March 2, 2025 | marketbeat.comIs SpringWorks Therapeutics, Inc. (SWTX) The Best Immunology Stock To Buy Now?March 1, 2025 | msn.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap Up - Should You Buy?SpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap Up - Should You Buy?March 1, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Bought by Los Angeles Capital Management LLCLos Angeles Capital Management LLC grew its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 30.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,760 shares of the company'sFebruary 28, 2025 | marketbeat.comSpringWorks Therapeutics (SWTX): Among the Best Performing Mid Cap Stocks to Buy According to AnalystsFebruary 26, 2025 | msn.comSpringWorks Therapeutics (SWTX): Among the Best Performing Mid Cap Stocks to Buy According to AnalystsFebruary 26, 2025 | msn.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Insider Bhavesh Ashar Sells 1,016 Shares of StockSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) insider Bhavesh Ashar sold 1,016 shares of the business's stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $61.19, for a total transaction of $62,169.04. Following the transaction, the insider now owns 62,053 shares in the company, valued at approximately $3,797,023.07. This represents a 1.61 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.February 25, 2025 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) CEO Sells 29,328 SharesSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) CEO Saqib Islam sold 29,328 shares of the company's stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $60.30, for a total transaction of $1,768,478.40. Following the completion of the transaction, the chief executive officer now owns 1,034,625 shares of the company's stock, valued at approximately $62,387,887.50. This trade represents a 2.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.February 25, 2025 | marketbeat.comInsider Selling: SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Director Sells 47,600 Shares of StockSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) Director Daniel Lynch sold 47,600 shares of the firm's stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $60.22, for a total transaction of $2,866,472.00. Following the sale, the director now owns 82,944 shares of the company's stock, valued at approximately $4,994,887.68. The trade was a 36.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.February 25, 2025 | marketbeat.com Remove Ads Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SWTX Media Mentions By Week SWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SWTX News Sentiment▼1.140.80▲Average Medical News Sentiment SWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SWTX Articles This Week▼65▲SWTX Articles Average Week Remove Ads Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dr. Reddy's Laboratories News Today Moderna News Today Ascendis Pharma A/S News Today Qiagen News Today Viatris News Today Roivant Sciences News Today Lantheus News Today Revolution Medicines News Today BridgeBio Pharma News Today TG Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SWTX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SWTX Stock Free SWTX Stock Alerts